Print
Additional PK Data
.gif)
In this case MeltDose® bioavailability improvement enabled further development of this very poorly soluble compound
In this case MeltDose® bioavailability improvement was significantly better than the microemulsion formulation
In this case MeltDose® bioavailability improvement was significantly better than the commercial nanoparticle suspension formulation
In this case MeltDose® demonstrated bioavailability improvement 8 times better than commercially available formulation
In this case MeltDose® demonstrated bioavailability improvement two-fold better than commercially available formulation
http://www.meltdose.com/files/./LCP_503px_PL_009_1(1).gif
http://www.meltdose.com/files/data photos/LCP_503px_PL009(1).gif
http://www.meltdose.com/files/data photos/LCP_503px_PL007(1).gif
http://www.meltdose.com/files/data photos/LCP_503px_danazolie(1).gif
http://www.meltdose.com/files/data photos/LCP_503px_isotretioin(1).gif
Clinically Proven Technology
- The ability of MeltDose® technology to increase bioavailability and/or reduce food effect has been confirmed in numerous clinical studies with a range of poorly soluble compounds
- MeltDose® technology is the basis for partnerships between LCP and several leading international pharmaceutical companies